echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetologia: Using human genetic data to study the effect of glucose-dependent insulin-promoting polypeptide signals on cardiometabolism

    Diabetologia: Using human genetic data to study the effect of glucose-dependent insulin-promoting polypeptide signals on cardiometabolism

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Glucose-dependent insulinotropic polypeptide (also known as gastric inhibitory polypeptide, GIP) is an insulin polypeptide that stimulates insulin secretion after oral nutrient intake


    Glucose-dependent insulinotropic polypeptide (also known as gastric inhibitory polypeptide, GIP) is an insulin polypeptide that stimulates insulin secretion after oral nutrient intake


    RESULTS: There were five results in the evidence that GIP and GIPR genes co-localize with the genetic associations of type 2 diabetes susceptibility


    Table Genome-wide association studies used to obtain summary statistics

    Table Genome-wide association studies used to obtain summary statistics

    Figure (A) OR and (be) effect size estimation for heart failure risk (MRβ coefficient, body mass index [b], C-reactive protein [c], high-density lipoprotein cholesterol [d] and triacylglycerol levels [e], All in SD) and its 95% cis-acting halved the risk of type 2 diabetes by genetic agents


    Figure (A) OR and (be) effect size estimation for heart failure risk (MRβ coefficient, body mass index [b], C-reactive protein [c], high-density lipoprotein cholesterol [d] and triacylglycerol levels [e], All in SD) and its 95% cis-acting halved the risk of type 2 diabetes by genetic agents


    This study provides genetic evidence that the beneficial effects of sustained GIP signaling on cardiometabolic health are greater than expected to improve blood glucose control alone


    Karhunen V, Daghlas I, Zuber V,et al.


    Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.